
|Articles|February 1, 2008
Insomnia drug should be classified under Schedule IV, DEA says
Drug Enforcement Administration proposes placing indiplon in Schedule IV
Advertisement
The Drug Enforcement Administration has proposed placing
To see more Daily News articles,
To go to the Drug Topics homepage,
Ā
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
2
FDA Approves XFG-Targeted COVID-19 Vaccines From Multiple Companies
3
FDA Approves Stelara for Pediatric Ulcerative Colitis
4
FAQ: What the RFI on Vaccine Categories Means for Pharmacists
5




























